HROW Market Cap History

Below is a table of the HROW market cap history going back to 11/12/2018:

Date HROW Market Cap

Also see: HROW Shares Outstanding History
and HROW YTD Return
HROW Historical Market Cap:
+35.06% CAGR
HROW Historical Market Cap: +35.06% CAGR

Mouse over chart for data details
11/12/2018 ...11/13/2023
Harrow is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures. We show 22 historical shares outstanding datapoints in our HROW shares outstanding history coverage, used to compute HROW market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing HROW market cap history over the course of time is important for investors interested in comparing HROW's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of HROW versus a peer is one thing; comparing HROW market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like HROW can fluctuate over the course of history. With this page we aim to empower investors researching HROW by allowing them to research the HROW market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree HROW Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Harrow Health (HROW) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

HRTX Market Cap History
HSCS Market Cap History
HSDT Market Cap History
HSGX Market Cap History
HSIC Market Cap History
HSKA Market Cap History
HSTO Market Cap History
HTBX Market Cap History
HTGM Market Cap History
HUMA Market Cap History
More Healthcare companies »


HROW Market Cap History | | Copyright © 2017 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.